Literature DB >> 31409908

Author Correction: Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma.

Junya Peng1, Bao-Fa Sun2,3,4, Chuan-Yuan Chen2,3, Jia-Yi Zhou2,3, Yu-Sheng Chen2,3, Hao Chen5, Lulu Liu1, Dan Huang1, Jialin Jiang5, Guan-Shen Cui2,3, Ying Yang2,3,4, Wenze Wang6, Dan Guo1,7, Menghua Dai5, Junchao Guo5, Taiping Zhang5, Quan Liao5, Yi Liu8, Yong-Liang Zhao2,3,4, Da-Li Han2,3,4, Yupei Zhao9,10, Yun-Gui Yang11,12,13, Wenming Wu14.   

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Entities:  

Year:  2019        PMID： 31409908      PMCID： PMC6796835          DOI： 10.1038/s41422-019-0212-1

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


  8 in total

1.  Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells.

Authors:  Mi He; Bhavesh Soni; Petra C Schwalie; Tamara Hüsser; Caroline Waltzinger; Duvini De Silva; Ylva Prinz; Laura Krümpelmann; Samuele Calabro; Ines Matos; Christine Trumpfheller; Marina Bacac; Pablo Umaña; Mitchell P Levesque; Reinhard Dummer; Maries van den Broek; Stephan Gasser
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

2.  Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer.

Authors:  Adam C Mueller; Miles Piper; Andrew Goodspeed; Shiv Bhuvane; Jason S Williams; Shilpa Bhatia; Andy V Phan; Benjamin Van Court; Kathryn L Zolman; Brisa Peña; Ayman J Oweida; Sara Zakem; Cheryl Meguid; Michael W Knitz; Laurel Darragh; Thomas E Bickett; Jacob Gadwa; Luisa Mestroni; Matthew R G Taylor; Kimberly R Jordan; Peter Dempsey; M Scott Lucia; Martin D McCarter; Marco Del Chiaro; Wells A Messersmith; Richard D Schulick; Karyn A Goodman; Michael J Gough; Casey S Greene; James C Costello; Antonio Galveo Neto; David Lagares; Kirk C Hansen; Adrie Van Bokhoven; Sana D Karam
Journal:  Cancer Res       Date:  2021-02-01       Impact factor: 12.701

3.  A Cancer Cell Cluster Marked by LincRNA MEG3 Leads Pancreatic Ductal Adenocarcinoma Metastasis.

Authors:  Hong Pan; Huanrong Diao; Wen Zhong; Taifang Wang; Ping Wen; Chunli Wu
Journal:  Front Oncol       Date:  2021-05-13       Impact factor: 6.244

4.  Molecular Features of Cancer-associated Fibroblast Subtypes and their Implication on Cancer Pathogenesis, Prognosis, and Immunotherapy Resistance.

Authors:  Phillip M Galbo; Xingxing Zang; Deyou Zheng
Journal:  Clin Cancer Res       Date:  2021-02-23       Impact factor: 13.801

5.  Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma.

Authors:  Robyn D Gartrell; Thomas Enzler; Pan S Kim; Benjamin T Fullerton; Ladan Fazlollahi; Andrew X Chen; Hanna E Minns; Subha Perni; Stuart P Weisberg; Emanuelle M Rizk; Samuel Wang; Eun Jeong Oh; Xinzheng V Guo; Codruta Chiuzan; Gulam A Manji; Susan E Bates; John Chabot; Beth Schrope; Michael Kluger; Jean Emond; Raul Rabadán; Donna Farber; Helen E Remotti; David P Horowitz; Yvonne M Saenger
Journal:  Oncoimmunology       Date:  2022-05-05       Impact factor: 7.723

6.  Heterocellular OSM-OSMR signalling reprograms fibroblasts to promote pancreatic cancer growth and metastasis.

Authors:  Brian Y Lee; Elizabeth K J Hogg; Christopher R Below; Alexander Kononov; Adrian Blanco-Gomez; Felix Heider; Jingshu Xu; Colin Hutton; Xiaohong Zhang; Tamara Scheidt; Kenneth Beattie; Angela Lamarca; Mairéad McNamara; Juan W Valle; Claus Jørgensen
Journal:  Nat Commun       Date:  2021-12-17       Impact factor: 14.919

Review 7.  OMICS Applications for Medicinal Plants in Gastrointestinal Cancers: Current Advancements and Future Perspectives.

Authors:  Rongchen Dai; Mengfan Liu; Xincheng Xiang; Yang Li; Zhichao Xi; Hongxi Xu
Journal:  Front Pharmacol       Date:  2022-02-04       Impact factor: 5.810

8.  Single-cell transcriptomics reveals heterogeneous progression and EGFR activation in pancreatic adenosquamous carcinoma.

Authors:  Xin Zhao; Han Li; Shaocheng Lyu; Jialei Zhai; Zhiwei Ji; Zhigang Zhang; Xinxue Zhang; Zhe Liu; Huaguang Wang; Junming Xu; Hua Fan; Jiantao Kou; Lixin Li; Ren Lang; Qiang He
Journal:  Int J Biol Sci       Date:  2021-06-22       Impact factor: 6.580
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.